Paul Treacy, SVP, Technical Operations at Jazz Pharmaceuticals plc (JAZZ), sold 2,579 shares at $137.47 ($355K) on 2016-08-16, disclosed to the SEC on 2016-08-18.
Open-market sale of $355k JAZZ by SVP, Technical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.46 | 5 | $687 | 0.2% |
| 2 | $137.47 | 1,287 | $177K | 49.9% |
| 3 | $137.47 | 1,287 | $177K | 49.9% |
| Total | $137.47 avg | 2,579 | $355K | 100% |
| Filing → |
| JAZZ | SELL | 2019-03-04 | $195K | — | Filing → |
| JAZZ | SELL | 2018-08-13 | $462K | — | Filing → |
| JAZZ | SELL | 2018-03-07 | $168K | — | Filing → |